Revenue
attach_money719M USD
YoY +8.6%
SUPNSupernus Pharmaceuticals, Inc.$ --
Supernus Pharmaceuticals, Inc.
SUPN
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-37M USD
YoY -145.1%
Net Income
verified-39M USD
YoY -152.2%
EPS
pie_chart-0.68USD
YoY -150.7%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress-22.1%Below Target
Revenue Progress719M
Revenue Forecast702.5M
Net Income Progress-38.5M
Net Income Forecast174.5M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.